Dr. Maureen W. Daye, MD

Dr. Daye practices at NewYork-Presbyterian Westchester in Bronxville, New York.

Dr. Daye's NPI, 1316959026, was assigned on August 12, 2006. Dr. Daye graduated from SUNY Upstate Medical University in 1989. Dr. Daye holds New York license 195948.

Dr. Daye's primary practice is NewYork-Presbyterian Westchester, at 55 Palmer Ave, Bronxville, NY 10708. The practice phone is (914) 787-5008.

Dr. Daye's primary practice is NewYork-Presbyterian Westchester in Bronxville, New York. Dr. Daye is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is NewYork-Presbyterian Medical Group Westchester. Dmand AI also links Dr. Daye to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Daye practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Daye's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Daye is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Daye's licenses on file in 5 states: New York, Florida, South Carolina, Massachusetts and Pennsylvania.

Dmand AI lists upper GI endoscopy among the conditions Dr. Daye treats.

CMS data shows 496 Medicare services from Dr. Daye across 5 procedure codes in 2024, for 236 Medicare patients. Medicare paid $35,800 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 236 Medicare patients who saw Dr. Daye in 2024. The largest group is 75 to 84, with 89 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Daye's median patient age at 70, with 60% women.

In 2019, Dr. Daye wrote 22 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $537 in total drug cost. In 2018, CMS named 299 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Daye for performance year 2024, reported through an alternative payment model (APM). Dr. Daye accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 47 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Daye, more than 62% of the clinicians it reports for that procedure.

CMS Open Payments shows 34 general payments to Dr. Daye from 10 drug and device companies from 2016 to 2018. Food and beverage make up the largest share, 100% of the total. Valeant Pharmaceuticals International paid the most, $141.

Dmand AI lists 1 award for Dr. Daye, most recently CMS Stage 1 2012 in 2012.

Dr. Daye graduated from SUNY Upstate Medical University in 1989.

Dr. Daye is in network with 7 carriers, including Aetna, Excellus BlueCross BlueShield and MVP Health Care. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.